Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.42788 | 71 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.28475 | 69 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.35879 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.05935 | 67 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.21294 | 69 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.5496 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.52562 | 72 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.3876 | 70 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.25353 | 69 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.23697 | 69 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.25312 | 69 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.11363 | 67 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.37399 | 70 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.51638 | 72 |